How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/delayed-administration-of-convalescent-plasma.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Delayed administration of convalescent plasma — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delayed administration of convalescent plasma (Delayed administration of convalescent plasma) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immunoglobulin/passive immunotherapy. Area: Immunology/Infectious Disease.

phase 3 Immunoglobulin/passive immunotherapy Immunology/Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Delayed administration of convalescent plasma (Delayed administration of convalescent plasma) — UMC Utrecht. Convalescent plasma transfers antibodies and immune factors from recovered patients to provide passive immunotherapy against infectious disease.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Delayed administration of convalescent plasma TARGET	Delayed administration of convalescent plasma	UMC Utrecht	phase 3	Immunoglobulin/passive immunotherapy
Convalescent Plasma	Convalescent Plasma	Hackensack Meridian Health	phase 3	Immunoglobulin/Passive immunotherapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immunoglobulin/passive immunotherapy class)

UMC Utrecht · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Delayed administration of convalescent plasma — Competitive Intelligence Brief. https://druglandscape.com/ci/delayed-administration-of-convalescent-plasma. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab